The model-based analysis estimated ψ as 0.96 and 2.2 indicating slightly synergistic/additive and antagonistic interactions for CIS and CIM for OCT2-negative cell line, Huh7, and OCT2-positive cell line, MDA-MB-468 cell lines, respectively. Here, SLC22A2 is linked to in situ carcinoma.